Keyphrases
Intravenous Immunoglobulin (IVIg)
100%
Autoimmune Blistering Diseases
100%
Intravenous Immunoglobulin Therapy
37%
Pemphigus
25%
Histology
12%
Statistical Analysis
12%
Safety Profile
12%
Clinical Outcomes
12%
English Language
12%
Number of Participants
12%
Biological Agents
12%
Chronic Inflammatory Diseases
12%
Randomized Controlled Trial
12%
B Cells
12%
Clinical Syndromes
12%
Kawasaki Disease
12%
Good Safety
12%
Bone Marrow Transplantation
12%
UK National Health Service
12%
Immunopathology
12%
Pediatric AIDS
12%
Clinical Symptoms
12%
Serologic Study
12%
PubMed Database
12%
Immune-mediated Inflammatory Diseases
12%
Primary Immunodeficiency
12%
US FDA
12%
Corticosteroid-sparing
12%
Serious Adverse Effects
12%
Best Available Evidence
12%
Immune Thrombocytopenic Purpura
12%
Efficacy Comparison
12%
Medicine and Dentistry
Immunoglobulin
100%
Diseases
100%
Intravenous Immunoglobulin Therapy
37%
Pemphigus
25%
Pediatrics
12%
Randomized Controlled Trial
12%
Biological Product
12%
Kawasaki Disease
12%
B-Cell Chronic Lymphocytic Leukemia
12%
English (Language)
12%
Idiopathic Thrombocytopenic Purpura
12%
Immunopathology
12%
Inflammatory Disorder
12%
Bone Marrow Transplantation
12%
Immune Deficiency
12%
Adverse Effect
12%
Pharmacology, Toxicology and Pharmaceutical Science
Immunoglobulin
100%
Diseases
100%
Immunotherapy
37%
Randomized Controlled Trial
12%
Syndrome
12%
Chronic Lymphatic Leukemia
12%
Biological Product
12%
Immune Deficiency
12%
Idiopathic Thrombocytopenic Purpura
12%
Mucocutaneous Lymph Node Syndrome
12%
Immunopathology
12%
Immunology and Microbiology
Intravenous Immunoglobulin
100%
Intravenous Immunoglobulin Therapy
37%
Pemphigus
25%
B Cell
12%
Bone Marrow Transplantation
12%
Immunopathology
12%
Biological Product
12%
Inflammatory Disorder
12%
Idiopathic Thrombocytopenic Purpura
12%
Medline
12%
Kawasaki Disease
12%
Primary Immunodeficiency
12%